共 41 条
[1]
Rubin LJ(1997)Primary pulmonary hypertension N Engl J Med 336 111-117
[2]
Abenhaim L(1996)Appetite-suppressant drugs and the risk of primary pulmonary hypertension N Engl J Med 335 609-616
[3]
Moride Y(1997)Mapping of familial primary pulmonary hypertension locus (PPH1) to chromosome 2q31-32 Circulation 95 2603-2606
[4]
Brenot F(1998)Inhaled nitric oxide in primary pulmonary hypertension: a safe and effective agent for predicting response to nifedipine J Am Coll Cardiol 32 1068-1073
[5]
Morse JH(1998)Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension N Engl J Med 338 273-277
[6]
Jones AC(1987)High-dose calcium channelblocking therapy for primary pulmonary hypertension: evidence for long-term reduction in pulmonary arterial pressure and regression of right ventricular hypertrophy Circulation 76 135-141
[7]
Barst RJ(1992)The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension N Engl J Med 327 76-81
[8]
Ricciardi MJ(1984)Adverse hemodynamic and clinical effects of calcium channel blockage in pulmonary hypertension secondary to obliterative pulmonary vascular disease J Am Coll Cardiol 4 890-901
[9]
Knight BP(1996)A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension N Engl J Med 334 296-301
[10]
Martinez FJ(1997)Primary pulmonary hypertension: improved long-term effects and survival with continuous intravenous epoprostenol infusion J Am Coll Cardiol 30 343-349